Jun 18, 2021
n this episode, Alan Patrick from Asia Medical Solutions joins IMI’s and INL's Founder Graeme Bradshaw to discuss practitioners' frequently asked questions on H.Pylori and related digestive complaints, a topic in which Graeme has a wealth of clinical experience.
Graeme and Alan discuss the discovery and epidemiology of the bacteria and expand on pathological consequences for patients and whether it can be innocuous.
They cover how to measure H.Pylori, what the different methods of diagnostic testing show and what the results would mean for clinical application.
The GIMAP is a quantitative diagnostic test, flagging when low levels of H.Pylori are present which is often missed by other lab tests, they discuss what this means, the H. pylori decision-making process; when to treat or not to treat.
As the conversion develops, they talk about how you can use H.Pylori as a barometer for digestive function, which is not only vital in itself but crucial for solving the route cause of many digestive conditions that patient present with.